WallStreetZenWallStreetZen

NASDAQ: ETNB
89bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for ETNB

Based on 5 analysts offering 12 month price targets for 89bio Inc.
Min Forecast
$14.00+62.22%
Avg Forecast
$27.00+212.86%
Max Forecast
$33.00+282.39%

Should I buy or sell ETNB stock?

Based on 5 analysts offering ratings for 89bio Inc.
Buy
Strong Buy
2 analysts 40%
Buy
2 analysts 40%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ETNB stock forecasts and price targets.

ETNB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-17
lockedlocked$00.00+00.00%2024-05-17
lockedlocked$00.00+00.00%2024-05-15
lockedlocked$00.00+00.00%2024-04-22
lockedlocked$00.00+00.00%2024-03-01

1 of 1

Forecast return on equity

Is ETNB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.27%

Forecast return on assets

Is ETNB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ETNB revenue forecast

What is ETNB's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$30.7M
Avg 2 year Forecast
$204.7M
Avg 3 year Forecast
$586.4M

ETNB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ETNB$8.63$27.00+212.86%Buy
PRME$7.08$14.83+109.51%Strong Buy
ZNTL$12.07$29.00+140.27%Buy
ABVX$13.64$36.00+163.93%Strong Buy
VRDN$13.45$30.50+126.77%Buy

89bio Stock Forecast FAQ

Is 89bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ETNB) stock is to Buy ETNB stock.

Out of 5 analysts, 2 (40%) are recommending ETNB as a Strong Buy, 2 (40%) are recommending ETNB as a Buy, 1 (20%) are recommending ETNB as a Hold, 0 (0%) are recommending ETNB as a Sell, and 0 (0%) are recommending ETNB as a Strong Sell.

If you're new to stock investing, here's how to buy 89bio stock.

What is ETNB's revenue growth forecast for 2026-2028?

(NASDAQ: ETNB) 89bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

89bio's revenue in 2024 is $0.On average, 4 Wall Street analysts forecast ETNB's revenue for 2026 to be $3,022,553,187, with the lowest ETNB revenue forecast at $744,766,865, and the highest ETNB revenue forecast at $4,703,738,944. On average, 4 Wall Street analysts forecast ETNB's revenue for 2027 to be $20,135,465,799, with the lowest ETNB revenue forecast at $6,187,369,634, and the highest ETNB revenue forecast at $39,284,730,401.

In 2028, ETNB is forecast to generate $57,687,949,147 in revenue, with the lowest revenue forecast at $19,270,473,688 and the highest revenue forecast at $100,361,516,360.

What is ETNB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ETNB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ETNB's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ETNB price target, the average ETNB price target is $27.00, with the highest ETNB stock price forecast at $33.00 and the lowest ETNB stock price forecast at $14.00.

On average, Wall Street analysts predict that 89bio's share price could reach $27.00 by May 17, 2025. The average 89bio stock price prediction forecasts a potential upside of 212.86% from the current ETNB share price of $8.63.

What is ETNB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ETNB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.